Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cobel Darou is one of Iran’s largest private pharmaceutical companies. It focuses on research, registration, importation/manufacturing and marketing/distribution of prescription medicines across major therapeutic areas including cardiovascular disease, oncology/cancer care, diabetes/metabolic disorders, central nervous system disorders (neurology/psychiatry), internal medicine/general practice and vaccines. The company also offers antibiotics and analgesics/painkillers as well as medical devices. It collaborates with international partners for licensing specialized drugs for local production. Cobel Darou holds significant market share in Iran’s pharma sector and has expanded into distribution through subsidiaries like AdoraTeb Distribution Company. It does not appear to develop novel NCEs or biologics itself but rather focuses on bringing established therapies to the Iranian market via partnerships or licensing agreements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cobel Darou.